『New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]』のカバーアート

New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

New drugs for anemia of lower-risk MDS [MDS Patient & Family Report]

無料で聴く

ポッドキャストの詳細を見る
MDS experts Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss new trials presented in the last meeting of the American Society of Hematology (ASH) 2023. They focus on luspatercept, imetelstat and roxodustat.
adbl_web_anon_alc_button_suppression_c
まだレビューはありません